Largest Study to Date Supports CRC Screening Before Age 50

The study provides the most accurate estimate of neoplasia prevalence in individuals aged 45-49 years and supports the benefits of screening in this younger age group.

Related Keywords

New York ,United States ,Boston ,Massachusetts ,Peters Liang ,Andrewt Chan , ,Grossman School Of Medicine ,Harvard Medical School ,New York City ,Medscape Medical ,Before Age ,Massachusetts General Hospital ,Medscape Medical News ,Colorectal Cancer ,Neoplasm ,Tumor ,Colorectal Cancer Screening ,Colon Cancer Screening ,Preventive Medicine Screening Recommendations ,Colonoscopy ,Drug Reaction ,Endoscopy ,Patient Safety ,Polyp ,